Year To Quarter End Consolidated Statement Of Comprehensive Income

Fuji Pharma Co.,Ltd. - Filing #7610243

Concept 2021-10-01 to
2022-03-31
2020-10-01 to
2021-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
1,834,000,000 JPY
2,022,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
861,000,000 JPY
136,000,000 JPY
Deferred gains or losses on hedges
39,000,000 JPY
JPY
Foreign currency translation adjustment
737,000,000 JPY
301,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-1,000,000 JPY
-3,000,000 JPY
Other comprehensive income
1,637,000,000 JPY
435,000,000 JPY
Comprehensive income
3,471,000,000 JPY
2,457,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,471,000,000 JPY
2,456,000,000 JPY
Comprehensive income attributable to non-controlling interests
0 JPY
0 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.